Disease modeling using iPSC technology

The research focuses on establishing in vitro models to study rare genetic diseases. We are applying induced pluripotent stem cell (iPSC) technology to produce patient-derived organ-specific cells. The generation of such disease models is a powerful tool to improve our understanding of the pathophysiology and to perform patient-specific drug screening.